Blogged on behalf of Current Partnering, Wildwood Ventures
Industry trends suggest that vaccine research and development is an increasingly active component of healthcare business development. In recent years vaccine partnering and M&A activity has significantly increased.
This article is abstracted from the recently published Vaccine Partnering Terms & Agreements report. Vaccine partnering has increased in frequency since 2007, to peak in 2010. In 2010, over 195 vaccine partnering deals were being reported in a year, before falling back slightly in recent years.
The Vaccine Partnering Terms and Agreements report published by Current Partnering provides full details of over 950 vaccine deals announced since 2007 and includes average deal terms including headline, upfront, milestone and royalty rates, where available. In addition, the report provides details of deals broken down by deal type, stage of development, company A-Z and technology type. Download this article to find out more >